Clinicians should carefully consider using noninvasive prenatal testing (NIPT) for the screening of chromosomal abnormalities in twin pregnancies because the combined positive predictive value (PPV) is limited and the screening efficiency is not stable, according to a prospective study.
Despite the inadvisability of performing early amniocentesis (EA) before 15 gestational weeks due to a high rate of miscarriage, a retrospective cohort study has found no significant difference in the procedure-related risk of miscarriage between EA, at around 14 weeks gestation, and mid-trimester amniocentesis (MA).
Here's what to look out for this week on Contemporary OB/GYN®:
The path to transformational leadership.
It's been a busy week for the Contemporary OB/GYN® team.
The course will cover a range of high-risk OB topics with an emphasis on clinical management, in the form of lectures, case presentations, panel discussions and audience participation.
Nearly 1 in 5 Black women and 1 in 6 Latina women who experience gestational diabetes mellitus (GDM) during pregnancy are diagnosed with type 2 diabetes within only 8 years postpartum, according to a study poster at the American Diabetes Association (ADA) virtual conference.
On June 2, 2021, ibrexafungerp (Brexafemme; Scynexis, Inc) was approved by the FDA for vulvovaginal candidiasis (VVC) in adult women and girls of reproductive age.
The penalties of deception can be much worse than medical negligence.
We hear from Christine Isaacs, MD about the new ASCCP guidelines and what they mean for ob/gyns.
A report in Pediatrics offered information on the clinical presentation, prevalence, and outcomes of a simultaneous serious bacterial infection with mastitis.
The unmet need for personalized follow-up care due to a wide variety of health burdens after treatment needs to be addressed.
As practitioners, advocating for our patients and managing common conditions to facilitate optimal pregnancy outcomes through preventative measures such as vaccination and addressing anemia have the potential for major impact.
His mother’s past medical history is significant for preeclampsia, previous opiate, and cocaine abuse, and current tobacco use, and she was incarcerated during the pregnancy. What's the diagnosis?
Debate and discussion about the origin of the virus that causes COVID-19 have been at the forefront of the global consciousness since the first cases were reported in December 2019.
For cervical cancer screening, human papillomavirus (HPV)–based screening modalities detect significantly more abnormal cervical cells than traditional liquid-based cytology (LBC) approaches, according to a study in JAMA Network Open.
This month's cover story examines iron-deficiency anemia in pregnancy and the role of intravenous iron. Plus, an extreme case of fraud demonstrates the reach of federal statutes enacted to prevent and punish those who commit health care fraud.
Anemia in pregnancy should be treated due to its connection to adverse maternal and neonatal outcomes.
What to look for this week on Contemporary OB/GYN®
It was a very busy week for the Contemporary OB/GYN® team.
A recent study shows that abnormal development is controlled by the genetics of the fetus and placenta, rather than the intrauterine environment.
Refer to this visual summary from SMFM wherever you practice.
When considering the “health” of a medical practice, much of the focus is on financial indicators: missing collections at the time of service, recurring denials, poor claims management and aging patient balances. However, another area needs attention but is often overlooked: patient satisfaction.
A significant uptick in telemedicine for managing diabetes in pregnancy occurred during the COVID-19 crisis, which should continue as the pandemic subsides, according to a session on telemedicine at the American Diabetes Association (ADA) virtual conference.
Results from one study found that many patients avoid going to the doctor because they feel uncomfortable seeking medical care or fear a serious illness. As providers, we need to recognize these issues and create a welcoming environment for all patients to ensure they don’t postpone care or avoid it entirely.
There are many reasons why a caregiver may refuse to have his or her child receive the human papillomavirus (HPV) vaccine, including safety concerns. A research letter examines whether those concerns have increased.
On June 2, 2021, ibrexafungerp (Brexafemme; Scynexis, Inc) was approved by the Food and Drug Administration for vulvovaginal candidiasis (VVC) in adult women and pediatric females who have begun menstruating. Ibrexafungerp is a triterpenoid antifungal that works by inhibiting the formation of the fungal cell wall. Ibrexafungerp (pronounced eye-BREX-ah-FUN-jerp) is the first approved drug of a novel class of antifungals.
Introducing Contemporary OB/GYN® Editorial Advisory Board member, Yalda Afshar, MD, PhD.
In addition to welcoming a newborn, parents may be unexpectedly billed for some hospitalization services, according to a research letter in JAMA Health Forum.
“Opioids affect placental development and function in animal models, but human data on their association with ischemic placental disease are limited,” wrote the authors.
